Research suggests that Bacillus clausii may support immune function in the context of intestinal infection, though the current evidence base is limited to a single in vitro laboratory study. That study found that a mixture of four B. clausii strains helped preserve gut barrier integrity in rotavirus-infected intestinal cells by maintaining cellular resistance, increasing protective proteins, and reducing harmful reactive oxygen species, while also appearing to dampen pro-inflammatory signaling pathways triggered by viral infection. These findings offer a plausible biological mechanism for immune-related benefits observed in clinical settings, but because the evidence comes exclusively from a cell-based laboratory model rather than human trials, it is not yet possible to draw firm conclusions about how these effects translate to immune function in living people. More research, including randomized controlled trials in human populations, would be needed to substantiate these preliminary findings.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Protective action of Bacillus clausii probiotic strains in an in vitro model ... | Other | 2020 | Supports | 100 |